Exclusion of People Living with HIV in Aggressive B-Cell Non-Hodgkin Lymphoma Studies: A Cross-Sectional Analysis of Clinical Trials from 2014 to 2024
Likely partly due to advocacy from ASCO, NCI, and NCCN, there was a significant decrease in exclusion among PLWH in US-based NHL clinical trials. Future research should analyze the safety and efficacy of immunotherapy in PLWH to foster inclusion and reduce stigma among physicians and researchers.
Authors
- Ajay K. Gopal (ORCID: https://orcid.org/0000-0003-3023-6834)
- Daniel J. Olivieri (ORCID: https://orcid.org/0000-0003-2684-4941)
- Thomas S. Uldrick (ORCID: https://orcid.org/0000-0001-6959-0924)
- Manoj Menon (ORCID: https://orcid.org/0000-0002-4981-0376)
Institutions
- University of Washington (US)
- Fred Hutch Cancer Center (US)
Publication Details
- Journal
- Cancer Investigation
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1080/07357907.2025.2462568
- Citations
- 3
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.14